Reduction of Cephalic Arteriovenous Shunting by Ergotamine is Not Mediated by 5-HT1-like or 5-HT2 Receptors

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1989 Jun 1

PMID 2758221

Citations 8

Authors

A H Bom

J P Heiligers

P R Saxena

P D Verdouw

Affiliations

Soon will be listed here.

Abstract

1. The potent, antimigraine drug ergotamine has affinity for both 5-HT1 and 5-HT2 binding sites and constricts arteriovenous anastomoses. Since 5-HT also constricts arteriovenous anastomoses (mainly via 5-HT1-like receptors), this study investigates the involvement of 5-HT receptors in the ergotamine-induced reduction of arteriovenous shunting in the carotid circulation of the cat and pig. 2. In the cat, ergotamine (3, 10 and 30 micrograms kg-1, i.v.) reduced carotid blood flow, predominantly by a reduction in arteriovenous anastomotic blood flow. Pretreatment with ketanserin (0.5 mg kg-1, i.v.) or methiothepin (1 mg kg-1, i.v.) did not antagonize the effects of ergotamine. 3. In the pig, ergotamine (2.5, 5, 10 and 20 micrograms kg-1, i.v.) also reduced carotid blood flow and arteriovenous shunting, which was not affected by pretreatment with methiothepin (1 mg kg-1, i.v.). 4. These results suggest that the reduction by ergotamine in the shunting of carotid arterial blood via cephalic arteriovenous anastomoses is not mediated by 5-HT1-like or 5-HT2 receptors.

Citing Articles

Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat.

Lambert G, Donaldson C, Hoskin K, Boers P, Zagami A Naunyn Schmiedebergs Arch Pharmacol. 2004; 369(6):591-601.

PMID: 15197536 DOI: 10.1007/s00210-004-0935-4.

Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action.

Hubert J, Delumeau J, Glowinski J, Premont J, Doble A Br J Pharmacol. 1994; 113(1):261-7.

PMID: 7812619 PMC: 1510058. DOI: 10.1111/j.1476-5381.1994.tb16203.x.

Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.

Den Boer M, Villalon C, Heiligers J, Humphrey P, Saxena P Br J Pharmacol. 1991; 102(2):323-30.

PMID: 1849764 PMC: 1918020. DOI: 10.1111/j.1476-5381.1991.tb12173.x.

Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.

Den Boer M, Heiligers J, Saxena P Br J Pharmacol. 1991; 104(1):183-9.

PMID: 1664762 PMC: 1908277. DOI: 10.1111/j.1476-5381.1991.tb12405.x.

Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.

Buzzi M, Moskowitz M, Peroutka S, Byun B Br J Pharmacol. 1991; 103(2):1421-8.

PMID: 1653072 PMC: 1908367. DOI: 10.1111/j.1476-5381.1991.tb09805.x.

References

Saxena P . Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine. Headache. 1974; 13(4):142-63. DOI: 10.1111/j.1526-4610.1974.hed1304142.x. View

Rowbotham G, Little E . NEW CONCEPTS ON THE AETIOLOGY AND VASCULARIZATION OF MENINGIOMATA; THE MECHANISM OF MIGRAINE; THE CHEMICAL PROCESSES OF THE CEREBROSPINAL FLUID; AND THE FORMATION OF COLLECTIONS OF BLOOD OR FLUID IN THE SUBDURAL SPACE. Br J Surg. 1965; 52:21-4. DOI: 10.1002/bjs.1800520105. View

Spira P, Mylecharane E, Lance J . The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey. Res Clin Stud Headache. 1976; 4:37-75. View

Spira P, Mylecharane E, Misbach J, Duckworth J, Lance J . Internal and external carotid vascular responses to vasoactive agents in the monkey. Neurology. 1978; 28(2):162-73. DOI: 10.1212/wnl.28.2.162. View

Johnston B, Saxena P . The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head. Br J Pharmacol. 1978; 63(3):541-9. PMC: 1668089. DOI: 10.1111/j.1476-5381.1978.tb07810.x. View

Bell C, Lang W, Laska F . Dopamine-containing axons supplying the arterio-venous anastomoses of the canine paw pad. J Neurochem. 1978; 31(5):1329-33. DOI: 10.1111/j.1471-4159.1978.tb06259.x. View

Saxena P . Arteriovenous shunting and migraine. Res Clin Stud Headache. 1978; 6:89-102. View

Bell C, Lang W . Evidence for dopaminergic vasodilator innervation of the canine paw pad. Br J Pharmacol. 1979; 67(3):337-43. PMC: 2044003. DOI: 10.1111/j.1476-5381.1979.tb08685.x. View

Saxena P . Presynaptic inhibition by ergotamine of the responses to cardioaccelerator nerve stimulations in the cat. Eur J Pharmacol. 1979; 58(3):305-12. DOI: 10.1016/0014-2999(79)90479-5. View

10.

Schamhardt H, Verdouw P, van der Hoek T, Saxena P . Regional myocardial perfusion and wall thickness and arteriovenous shunting after ergotamine administration to pigs with a fixed coronary stenosis. J Cardiovasc Pharmacol. 1979; 1(6):673-86. DOI: 10.1097/00005344-197911000-00008. View

11.

Kronert H, Wurster R, PIERAU F, Pleschka K . Vasodilatory response of arteriovenous anastomoses to local cold stimuli in the dog's tongue. Pflugers Arch. 1980; 388(1):17-9. DOI: 10.1007/BF00582623. View

12.

Saxena P, Schamhardt H, FORSYTH R, Hoeve J . Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Comput Programs Biomed. 1980; 12(2-3):63-84. DOI: 10.1016/0010-468x(80)90053-7. View

13.

Saxena P, Verdouw P . Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol. 1982; 332:501-20. PMC: 1197412. DOI: 10.1113/jphysiol.1982.sp014427. View

14.

Puzich R, GIRKE W, Heidrich H, Rischke M . [Doppler ultrasound studies of the extracranial cerebral vessels in migraine patients after ergotamine tartrate administration]. Dtsch Med Wochenschr. 1983; 108(12):457-61. DOI: 10.1055/s-2008-1069578. View

15.

Saxena P, Koedam N, Heiligers J, Hof R . Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia. 1983; 3(2):71-81. DOI: 10.1046/j.1468-2982.1983.0302071.x. View

16.

Verdouw P, Jennewein H, Heiligers J, Duncker D, Saxena P . Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307. Eur J Pharmacol. 1984; 102(3-4):499-509. DOI: 10.1016/0014-2999(84)90571-5. View

17.

Saxena P, Verdouw P . 5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol. 1985; 84(2):533-44. PMC: 1987291. DOI: 10.1111/j.1476-5381.1985.tb12938.x. View

18.

Verdouw P, Jennewein H, Mierau J, Saxena P . N-(3-acetylaminophenyl)piperazine hydrochloride (BEA 1654), a putative 5-HT1 agonist, causes constriction of arteriovenous anastomoses and dilatation of arterioles. Eur J Pharmacol. 1985; 107(3):337-46. DOI: 10.1016/0014-2999(85)90259-6. View

19.

Saxena P, Verdouw P . Tissue blood flow and localization of arteriovenous anastomoses in pigs with microspheres of four different sizes. Pflugers Arch. 1985; 403(2):128-35. DOI: 10.1007/BF00584089. View

20.

Kaumann A . Two classes of myocardial 5-hydroxytryptamine receptors that are neither 5-HT1 nor 5-HT2. J Cardiovasc Pharmacol. 1985; 7 Suppl 7:S76-8. DOI: 10.1097/00005344-198500077-00022. View